文献速递产科麻醉

去甲肾上腺素间断静脉推注预防剖宫产腰麻低血压的序贯分配剂量探索研究

Norepinephrine Intermittent Intravenous Boluses to Prevent Hypotension During Spinal Anesthesia for Cesarean Delivery: A Sequential Allocation Dose-Finding Study.
PubMed 文献 · Anesth Analg · 2017-01-01

截断Dixon-Mood法估计ED90为5.49 μg(95%CI 5.15–5.83),等渗回归法为5.80 μg(95%CI 5.01–6.59)。结论认为该方案可行且未观察到不良结局,建议ED90剂量为6 μg。

要点

  • 择期剖宫产腰麻下间断静脉推注去甲肾上腺素预防低血压的ED90约为6 μg。
  • 截断Dixon-Mood法ED90为5.49 μg(95%CI 5.15–5.83),等渗回归法为5.80 μg(95%CI 5.01–6.59)。
  • 该方案未观察到不良结局,但需进一步比较去甲肾上腺素与去氧肾上腺素的效果与安全性。

核心结论

  • 择期剖宫产腰麻下间断静脉推注去甲肾上腺素预防低血压似乎可行,未观察到不良结局,建议ED90剂量为6 μg。

主要发现

  • 去甲肾上腺素间断静脉推注剂量为3、4、5、6、7或8 μg,每次收缩压降至基线100%以下时给予。
  • 主要结局为腰麻诱导至胎儿娩出期间维持收缩压不低于基线80%的成功率。
  • 截断Dixon-Mood法估计ED90为5.49 μg(95%CI 5.15–5.83),等渗回归法为5.80 μg(95%CI 5.01–6.59)。

关键数值与推荐

  • ED90定义为90%产妇维持收缩压不低于基线80%的有效剂量。
  • 截断Dixon-Mood法ED90为5.49 μg(95%CI 5.15–5.83),等渗回归法ED90为5.80 μg(95%CI 5.01–6.59)。
  • 实际建议ED90剂量为6 μg。

临床怎么用

  • 择期剖宫产腰麻下可考虑间断静脉推注去甲肾上腺素约6 μg预防低血压。
  • 需进一步研究比较去甲肾上腺素与去氧肾上腺素间断静脉推注的疗效与安全性。

局限性

  • 去甲肾上腺素作为间断推注用于剖宫产低血压防治尚属新尝试,需进一步比较研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The use of phenylephrine as the first-line agent for prevention and treatment of maternal hypotension during cesarean delivery (CD) may reduce cardiac output, posing a theoretical risk to mother and fetus. Norepinephrine has been suggested as a potential alternative, because its β-adrenergic effects might result in greater heart rate and cardiac output than phenylephrine. The use of norepinephrine to prevent and treat hypotension during CD is new, and its use as a bolus has not been fully determined in this context. The purpose of this study was to determine the effective norepinephrine dose, when given as intermittent intravenous (IV) boluses, to prevent postspinal hypotension in 90% of women undergoing elective CD (ED90). METHODS: This was a prospective, double-blind sequential allocation dose-finding study, using the biased coin up-and-down design. Forty-term pregnant women undergoing elective CD under spinal anesthesia received a set intermittent norepinephrine bolus of either 3, 4, 5, 6, 7, or 8 µg every time their systolic blood pressure (SBP) fell to below 100% of baseline. The primary outcome was the success of the norepinephrine regimen to maintain SBP at or above 80% of baseline, from induction of spinal anesthesia to delivery of the fetus. Secondary outcomes included nausea, vomiting, hypertension (SBP > 120% of baseline), bradycardia (<50 bpm), upper sensory level of anesthesia to ice cold and umbilical artery and vein blood gases. The ED90 and 95% confidence intervals (CIs) were estimated using both truncated Dixon and Mood and isotonic regression methods. RESULTS: The estimated ED90 of norepinephrine was 5.49 µg (95% CI, 5.15-5.83) using the truncated Dixon and Mood method and 5.80 µg (95% CI, 5.01-6.59) using the isotonic regression method. CONCLUSIONS: The use of intermittent IV norepinephrine boluses to prevent spinal-induced hypotension in elective CD seems feasible and was not observed to be associated with adverse outcomes. Practically, we suggest an ED90 dose of 6 µg. Further work is warranted to elucidate the comparative effects of intermittent IV bolus doses of phenylephrine and norepinephrine, in terms of efficacy and safety.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Onwochei DN, Ngan Kee WD, Fung L, et al. Norepinephrine Intermittent Intravenous Boluses to Prevent Hypotension During Spinal Anesthesia for Cesarean Delivery: A Sequential Allocation Dose-Finding Study. Anesth Analg. 2017. PMID: 28248702. doi:10.1213/ANE.0000000000001846

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。